Following the successful launch of its newest grant program last year, garnering over 100 applications from the brightest early-career cancer researchers across Australia, Cure Cancer is now opening its grant round for 2024.
“The number of applications we received last year highlights the need for more funding opportunities for our hardworking scientists,” says Nikki Kinloch, CEO of Cure Cancer.
“We need bold ideas to significantly advance cancer research, and many of these come from emerging researchers who are often overlooked by most funding bodies. Sadly, this has caused some of the brightest minds to leave the field, and their promising novel approaches to cancer research were left unexplored.”
This year, the 56-year-old organisation made a concerted effort to raise awareness about its mission through collaboration with key partners, especially in states where applications have been low.
“Cure Cancer exists to change that narrative. I’m happy to report that this year, we’ve increased the number of research projects we’ve funded by 75%. With the help and support of our community, we are looking forward to funding even more brilliant scientists in the years to come,” added Kinloch.
“Early-career researchers need that extra support so we can grow our future research leaders.”
Early career researchers (defined by Cure Cancer as 0-7 cumulative years post PhD and accounting for career disruptions) working on cancer research can submit an EOI through Cure Cancer’s grant page for up to $100,000 per annum for up to two years of funding.
All applications will be competitively reviewed by an independent Grant Review Panel, EOI submissions will close at 5 pm AEST on 24th April 2023.
Related: Cure Cancer announces funding five new early-career researchers in 2023